Ensign Peak Advisors, Inc Imago Bio Sciences, Inc. Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $1.95 Million - $2.69 Million	138,000 Added 340.18%	178,567 $2.69 Million
Q2 2022 Aug 12, 2022	BUY	$11.81 - $20.92 $153,022 - $271,060	12,957 Added 46.93%	40,567 $543,000
Q1 2022 May 16, 2022	BUY	$16.97 - $25.0 $44,291 - $65,250	2,610 Added 10.44%	27,610 $532,000
Q4 2021 Feb 11, 2022	BUY	$16.22 - $29.69 $405,500 - $742,250	25,000 New	25,000 $593,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.